Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 11:28 am Purchase |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 70,995 7.500% |
16,954 (+31.37%) |
Filing History |
| 2023-02-13 8:14 pm Purchase |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 96,176 9.990% |
3,593 (+3.88%) |
Filing History |
| 2023-02-10 4:20 pm Unchanged |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
SEATTLE GENETICS INC SGEN |
46,327 5.000% |
0 (Unchanged) |
Filing History |
| 2023-02-10 10:22 am Unchanged |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 4.800% |
0 (Unchanged) |
Filing History |
| 2023-01-27 5:02 pm Purchase |
2023-01-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 50,000 5.400% |
37,500 (+300.00%) |
Filing History |
| 2023-01-26 5:01 pm Sale |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 12,500 1.300% |
-36,061 (-74.26%) |
Filing History |
| 2022-10-24 4:57 pm Purchase |
2022-10-13 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Lynx1 Capital Management LP | 47,808 5.100% |
47,808 (New Position) |
Filing History |
| 2022-02-14 3:20 pm Sale |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 54,041 5.900% |
-5,988 (-9.97%) |
Filing History |
| 2022-02-14 1:56 pm Purchase |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 92,583 9.990% |
22,563 (+32.22%) |
Filing History |
| 2022-02-14 06:22 am Sale |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Citadel Advisors LLC | 40,760 4.500% |
-775 (-1.87%) |
Filing History |
| 2022-02-14 06:08 am Unchanged |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Nussbaum Ran | 44,643 4.960% |
0 (Unchanged) |
Filing History |
| 2022-01-27 4:30 pm Purchase |
2022-01-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 48,561 5.400% |
48,561 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BLACKROCK INC BLK |
16,281 2.100% |
-29,111 (-64.13%) |
Filing History |
| 2021-07-06 4:03 pm Purchase |
2021-06-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Citadel Advisors LLC | 41,536 5.200% |
41,536 (New Position) |
Filing History |
| 2021-04-07 5:37 pm Purchase |
2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 5.660% |
44,803 (New Position) |
Filing History |
| 2021-04-02 4:20 pm Purchase |
2021-03-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
SEATTLE GENETICS INC SGEN |
46,327 6.200% |
46,327 (New Position) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 60,029 8.400% |
-9,665 (-13.87%) |
Filing History |
| 2021-02-16 07:31 am Purchase |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Nussbaum Ran | 44,643 6.400% |
44,643 (New Position) |
Filing History |
| 2021-02-12 4:20 pm Sale |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 70,020 9.990% |
-3,390 (-4.62%) |
Filing History |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
BLACKROCK INC BLK |
45,391 6.500% |
2,827 (+6.64%) |
Filing History |